ConductScience.org, home

Trial · NCT00884221

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryOngoing Pregnancy After One Fresh Embryo Replacement Cycle, Intention-to-treat (ITT) Analysis Set10-11 weeks after embryo transfer at the blastocyst stageTransvaginal ultrasound showing at least one intrauterine viable fetus 10-11 weeks after embryo transfer at the blastocyst stage
PrimaryOngoing Pregnancy After One Fresh Embryo Replacement Cycle, Per-protocol (PP) Analysis Set10-11 weeks after embryo transfer at the blastocyst stageTransvaginal ultrasound showing at least one intrauterine viable fetus 10-11 weeks after embryo transfer at the blastocyst stage
SecondaryEndocrine Profile (Estradiol), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryEndocrine Profile (FSH), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryEndocrine Profile (Free Androgen Index), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn. Free androgen index = (testosterone (nmol/L)/ sex hormone binding globulin (nmol/L))\*100
SecondaryEndocrine Profile (Luteinizing Hormone), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryEndocrine Profile (Progesterone), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryEndocrine Profile (Prolactin), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryEndocrine Profile (Sex Hormone Binding Globulin), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryEndocrine Profile (Testosterone), Intention-to-treat (ITT) Analysis SetOn the last day of stimulation, blood was drawn at least 8 hours after the previous injection of gonadotrophin and GnRH antagonistBlood samples for analysis of circulating concentrations of endocrine parameters were drawn
SecondaryNumber of Follicles of >= 12mm, 12-14 mm, 15-16 mm and >= 17 mm in Each Participant, Intention-to-treat (ITT) Analysis SetLast stimulation dayDuring the controlled ovarian stimulation, transvaginal ultrasound was performed to count the number of follicles and measure the size of the follicles.
SecondaryNumber of Oocytes Retrieved in Each Participant, Intention-to-treat (ITT) Analysis Set36 h after hCGOocyte retrieval took place 36h (± 2h) after hCG administration. At oocyte retrieval, the number of oocytes retrieved was recorded.
SecondaryFertilization, Intention-to-treat (ITT) Analysis Set1 day after oocyte retrieval (19 h post-insemination)Fertilized oocytes with 2 pronuclei were regarded as correctly fertilized. Fertilization was estimated as (Number of oocytes with 2 pronuclei / number of metaphase II oocytes)\*100
SecondaryBlastocyst Quality, Intention-to-treat (ITT) Analysis Set5 days after oocyte retrieval (120h post-insemination)
Blastocyst quality on day 5 was based on the blastocyst expansion and hatching status, inner cell mass grading and trophectoderm grading. Excellent-quality blastocysts were defined as those with blastocyst expansion and hatching status 4, 5 or 6, inner cell mass grading A, and trophectoderm grading A or B. Good-quality blastocysts were defined as those with blastocyst expansion and hatching status 3, 4, 5 or 6, inner cell mass grading A or B, and trophectoderm grading A or B.
SecondaryLive Birth for a Single Stimulation Cycle With Single Blastocyst Transfer From Fresh Embryo Replacement Cycle, Intention-to-treat (ITT) Analysis SetPost-trial information
SecondaryCumulative Live Birth for a Single Stimulation Cycle With Single Blastocyst Transfer From Fresh and 1 Year Frozen Embryo Replacement Cycles, Intention-to-treat (ITT) Analysis SetPost-trial information

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00884221/registered